Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Fluid and Imaging Biomarkers in Huntington's Disease

Broom EL, Hanson-Baiden J, Byrne LM.

Curr Neurol Neurosci Rep. 2026 Sep 24;26(1):51. doi: 10.1007/s11910-026-01522-1.

Phytocannabinoid cannabidiol (CBD) in neurodegenerative diseases: From polypharmacology to drug development

Zhang B, Nan J, Zhang Y, Zhang B, Ke C, Wang W, Wu T, Xia J, Yang F, He M, Tian L, Yang Z, Liang C.

Eur J Med Chem. 2026 Sep 23;320:119360. doi: 10.1016/j.ejmech.2026.119360. Online ahead of print.

Revealing the Mechanisms of Alzheimer's, Parkinson's and Huntington's Diseases Through Invertebrate Models

Ding X, Wang P, Zhou L, Li X.

Biology (Basel). 2026 Aug 10;15(16):1351. doi: 10.3390/biology15161351.

Theranostic Innovative Strategies for Brain Diseases: New Insights on Neurovascular Unit-Associated Pathological Changes in Neurodegenerative Disorders and Aging

Terribile G, Pedrinazzi M, Frigerio I, Sancini G, Combi R.

Int J Mol Sci. 2026 Aug 11;27(16):7165. doi: 10.3390/ijms27167165.

[Acute Chorea]

Herrera-Mora P, Kenai Cruz-Rio VS, Gonzalez-Gonzalez R, Delagarza-Pineda O, Zea-Vera A.

Medicina (B Aires). 2026 Aug;86 Suppl 3:149-156.

Quercetin as a Hypothesized Involvement of VMAT2 in Neurodegenerative Diseases-Mechanistic Insight and Therapeutic Applications

Sharma K, Vikram V, Jamwal P, Bhaumik S, Prasad N, Rohit, Juneja R.

Mol Neurobiol. 2026 Aug 28;63(1):862. doi: 10.1007/s12035-026-06164-5.

Mechanism and progress of deep brain stimulation in the treatment of neurological and psychiatric disorders

Yuan Y, Liu P, Yin C, Zhu J, Xu J, Xiong H, Xu R.

MedScience. 2026 Aug 29. doi: 10.1007/s11684-026-1231-1. Online ahead of print.

Chaperone-assisted selective autophagy (CASA) in polyglutamine-related diseases: From mechanisms to therapeutic perspectives

Tedesco B, Chierichetti M, Cristofani R, Poletti A.

J Huntingtons Dis. 2026 Sep 3:18796397261478173. doi: 10.1177/18796397261478173. Online ahead of print.

Microbiota-derived metabolite-GPCR signalling in neurodegeneration

Sharma A, Jatana N.

Neuroscience. 2026 Sep 4;615:312-333. doi: 10.1016/j.neuroscience.2026.09.001. Online ahead of print.

When machines see more: Digital technologies, measurement, and meaning in hyperkinetic movement disorders

Bhidayasiri R, Shin C, Albanese A.

Parkinsonism Relat Disord. 2026 Sep 2:108959. doi: 10.1016/j.parkreldis.2026.108959. Online ahead of print.

SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential

Duan J, Liu J, Meng Q, Liu J, Yang S, Zhou F, Cao J.

FASEB J. 2026 Sep 15;40(17):e72288. doi: 10.1096/fj.202602361RR.

Opto-CRISPR technologies in translational neuropharmacology

Lau CH, Xia Q, Liang Q, Guo R, Zhu H.

Neuropharmacology. 2026 Sep 9;301:111185. doi: 10.1016/j.neuropharm.2026.111185. Online ahead of print.

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation

Mittal D, Solanki P, Jain GK, Jhawat V, Kesharwani P, Dutt R, Arora S, Singh RP.

3 Biotech. 2026 Oct;16(10):420. doi: 10.1007/s13205-026-05048-8. Epub 2026 Sep 9.

Chorea-predominant SCA5 mimicking Huntington's disease: A case report with a novel SPTBN2 variant

Lei P, Chi Y, Xia J, Wang T, Zhong L.

Clin Park Relat Disord. 2026 Sep 17;15:100501. doi: 10.1016/j.prdoa.2026.100501. eCollection 2026.

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2)

Arnaud L, Monticielo OA, Piga M, Costedoat-Chalumeau N, Touma Z, Ruiz-Irastorza G, Bae SC, Bernatsky S, Bonfa E, Bottazzi F, Cervera R, Chehab G, Clarke AE, Dall'era M, Duarte-Garcia A, Espinosa G, Fortin PR, Fredi M, Gómez-Puerta JA, Izuka S, Jönsen A, Khmelinskii N, Legge A, Meisalu S, Moroni L, Orsolini G, Padjen I, Petri M, Pons-Estel G, Ramirez GA, Ramsey-Goldman R, Sciascia S, Tincani A, Triggiani M, Ugarte-Gil MF, Vinet E, Vital EM, Mosca M, Tani C; ERN ReCONNET–SLICC–SLEuro rare SLE taskforce member panel.

Lancet Rheumatol. 2026 Oct;8(10):e810-e821. doi: 10.1016/S2665-9913(26)00141-4. Epub 2026 Aug 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias